| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques
|
Denzler, Karen L.
|
|
2011
|
29 |
52 |
p. 9684-9690
7 p.
|
article
|
| 2 |
Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus
|
Lee, Sang-Won
|
|
2011
|
29 |
52 |
p. 9583-9587
5 p.
|
article
|
| 3 |
Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis
|
Scott, Pippa
|
|
2011
|
29 |
52 |
p. 9711-9721
11 p.
|
article
|
| 4 |
Editorial Board
|
|
|
2011
|
29 |
52 |
p. CO2-
1 p.
|
article
|
| 5 |
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
|
Liang, Zhenglun
|
|
2011
|
29 |
52 |
p. 9668-9674
7 p.
|
article
|
| 6 |
Financing and systems barriers to seasonal influenza vaccine delivery in community settings
|
Penfold, Robert B.
|
|
2011
|
29 |
52 |
p. 9632-9639
8 p.
|
article
|
| 7 |
Foot-and-mouth disease virus particles inactivated with binary ethylenimine are efficiently internalized into cultured cells
|
Martín-Acebes, Miguel A.
|
|
2011
|
29 |
52 |
p. 9655-9662
8 p.
|
article
|
| 8 |
Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria
|
Mateen, Farrah J.
|
|
2011
|
29 |
52 |
p. 9697-9701
5 p.
|
article
|
| 9 |
HLA-A2-restricted survivin-derived T-cell responses
|
Straten, Per thor
|
|
2011
|
29 |
52 |
p. 9582-
1 p.
|
article
|
| 10 |
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants
|
Grimprel, E.
|
|
2011
|
29 |
52 |
p. 9675-9683
9 p.
|
article
|
| 11 |
Immunogenicity of hepatitis B vaccine among hemodialysis patients: Effect of revaccination of non-responders and duration of protection
|
Chaves, Sandra S.
|
|
2011
|
29 |
52 |
p. 9618-9623
6 p.
|
article
|
| 12 |
Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: A systematic review and meta-analysis
|
Rückinger, Simon
|
|
2011
|
29 |
52 |
p. 9600-9606
7 p.
|
article
|
| 13 |
Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine
|
Zhao, Xiaojuan
|
|
2011
|
29 |
52 |
p. 9611-9617
7 p.
|
article
|
| 14 |
Immunological Correlates of Vaccine-Derived Protection Fondation Mérieux Conference Center ‘Les Pensières’ Veyrier-Du-Lac, France, Sept. 20–22, 2010
|
Schödel, Florian
|
|
2011
|
29 |
52 |
p. 9575-9577
3 p.
|
article
|
| 15 |
Methodologic reporting requirements for clinical trials
|
|
|
2011
|
29 |
52 |
p. 9578-
1 p.
|
article
|
| 16 |
Methods in vaccine effectiveness and safety studies: A critical need for vaccine confidence
|
Jacobsen, Steven J.
|
|
2011
|
29 |
52 |
p. 9573-9574
2 p.
|
article
|
| 17 |
Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness
|
Whiteman, Melissa C.
|
|
2011
|
29 |
52 |
p. 9702-9710
9 p.
|
article
|
| 18 |
Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: The results of a French prospective descriptive study
|
Omon, E.
|
|
2011
|
29 |
52 |
p. 9649-9654
6 p.
|
article
|
| 19 |
Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)
|
Díez-Domingo, Javier
|
|
2011
|
29 |
52 |
p. 9640-9648
9 p.
|
article
|
| 20 |
Reply to: Methodologic reporting requirements for clinical trials?
|
Poland, G.A.
|
|
2011
|
29 |
52 |
p. 9579-
1 p.
|
article
|
| 21 |
Reply to Morel et al.
|
Plotkin, Stanley A
|
|
2011
|
29 |
52 |
p. 9580-
1 p.
|
article
|
| 22 |
Reply to the letter by Dr. Stanley Plotkin
|
Morel, Sandra
|
|
2011
|
29 |
52 |
p. 9581-
1 p.
|
article
|
| 23 |
School-based vaccination: A systematic review of process evaluations
|
Cooper Robbins, Spring Chenoa
|
|
2011
|
29 |
52 |
p. 9588-9599
12 p.
|
article
|
| 24 |
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus
|
Denzler, Karen L.
|
|
2011
|
29 |
52 |
p. 9691-9696
6 p.
|
article
|
| 25 |
The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009
|
Kaposy, Chris
|
|
2011
|
29 |
52 |
p. 9607-9610
4 p.
|
article
|
| 26 |
Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark
|
Widgren, Katarina
|
|
2011
|
29 |
52 |
p. 9663-9667
5 p.
|
article
|
| 27 |
Vaccination by delayed treatment of infection
|
Stromberg, Sean P.
|
|
2011
|
29 |
52 |
p. 9624-9631
8 p.
|
article
|
Journal description